Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gynecologic 5Gastrointestinal 4Thoracic 3Breast 3Other hematologic neoplasm 2Tumor-Agnostic 1Plasma cell 1Myeloid 1Lymphoid 1Head & Neck 1

Conditions

Lung Neoplasms 2Smoking 1Lung Cancer Screening 1

Interventions

Carboplatin 351pembrolizumab 323Pemetrexed 248Cisplatin 220Paclitaxel 148Nivolumab 138durvalumab 134osimertinib 112atezolizumab 110Docetaxel 110Specimen Handling 91Radiotherapy 87Drug Therapy 85Magnetic Resonance Spectroscopy 77Etoposide 77Radiosurgery 72Gemcitabine 71Ipilimumab 54130-nm albumin-bound paclitaxel 54Bevacizumab 52cemiplimab 47tislelizumab 45Blood Specimen Collection 40Cetuximab 35Taxes 34Platinum 33Injections 33Biopsy 33Standard of Care 31Immunoglobulin G 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Mass Screening × Thoracic × 1 year × Clear all
NCT07408531 2026-04-13

LUNG-07: Advancing Precision-Based Lung Cancer Screening: Implementation, AI-Guided Risk Stratification, and Biomarker Integration (CREST AI)

University of Illinois at Chicago

Phase NA Recruiting
2,500 enrolled
Thoracic

Lung Cancer Screening

NCT04577599 2026-01-21

Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54

Wake Forest University Health Sciences

Phase NA Recruiting
1,160 enrolled
Thoracic

Lung Neoplasms, Smoking

NCT06535451 2025-12-24

DETECTO

Instituto Nacional de Cancerologia de Mexico

Recruiting
1,000 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡